Drug price disruption: Will the new Amazon deal have an impact?

Submitted by blackswan on Thu, 02/01/2018 - 23:01

A recent analysis by reporter Erin Mershon in STAT  offers five reasons why it is so very difficult to make drugs more affordable, despite President Trump’s repeated vow to lower prices. The five factors are:

Can the ASCO “Value Framework” work for myeloma patients?

Submitted by Dr. Brian GM Durie on Fri, 08/14/2015 - 02:18

Cancer drug costs are high. In an effort to rationalize the use of expensive drugs, the American Society of Clinical Oncology (ASCO) has proposed what they call a “Value Framework.” This framework uses a complex points system (See Fig 1. of article).